Genetic Testing Market Outlook 2030: Evaluating Market Growth, Size, and Share

1. Genetic Testing Industry Outlook 2030: Evaluating Market Growth, Size, and Share Trends sales@delvens.comwww.delvens.com

2. Genetic Testing Industry Outlook 2030: Evaluating Market Growth, Size, and Share Trends The Genetic Testing Market research report classifies the market trends relevant to the supply, requirement, and arrangement, at any rate, the new events. The report highlights huge drivers, restrictions, and positive chances to give a definite image of the market. The Genetic Testing Market research report gives complete details about the profitable emerging markets and examines insights into the markets' developing section. Furthermore, the Genetic Testing Market research report gives a complete evaluation of market shares, approaches, products, verification, regulatory approvals, copyright aspect, and manufacturing proficiency of the leading players. Get a Sample Copy of the Report: https://www.delvens.com/get-free-sample/genetic-testing-market-trends-forecast-till-2030 sales@delvens.com www.delvens.com

3. Market Overview The global Genetic Testing market size was estimated at USD 18.05 billion in 2023 and is projected to reach USD 35.62 billion in 2030 at a CAGR of 10.20% during the forecast period 2023-2030. Genetic tests are defined as medical devices available in kits and panels that are used to test people for genetic diseases. In addition, testing is done by taking blood samples from patients. These samples are then run on laboratory equipment using test kits. In addition, different tests are used to test for genetic disorders. For example, some genetic tests include predictive and asymptomatic testing, carrier testing, prenatal and neonatal testing, diagnostic testing, pharmacogenomic testing, and others. In addition, these tests are used to diagnose diseases such as cancer diagnosis, genetic disease and cardiovascular disease. The genetic testing market is expected to grow significantly in the future due to the increasing incidence of genetic disorders and cancer, and the growing awareness and acceptance of personalized medicine. For example, genetic testing, also known as pharmacogenetic testing, has been widely used in pharmacogenetics. In addition, advancements in genetic testing technologies are expected to boost the growth of the genetic testing market during the forecast period. However, standardization issues in genetic testing-based diagnostics and strict regulations on product approval are likely to slow down the growth of the genetic testing market during the forecast period. Conversely, untapped emerging markets in developing countries are expected to offer profitable opportunities for market participants. For example, the healthcare systems of developing countries such as Brazil, India and China have seen significant increases in investment in healthcare and infrastructure, resulting in increased demand for genetic testing in the region. sales@delvens.com www.delvens.com

4. Key Findings • The type segment is further fragmented into Predictive & Pre-symptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others. The prenatal and newborn testing segment held the dominant position and the highest revenue and is expected to maintain its dominant position during the forecast period. This is due to the increase in health awareness among people and the increase in mortality from genetic diseases worldwide. On the other hand, the pharmacogenomic testing segment is expected to witness the highest CAGR during the forecast period. This is expected to increase the use of personalized medicine worldwide. • The technology segment is further bifurcated into Cytogenetic Testing, Biochemical Testing, and Molecular Testing. The molecular testing segment has achieved the largest market share in genetic testing and will maintain its leading position during the forecast period. Growth in this segment is driven by molecular testing, which is the most widely used genetic testing technique. The technology is used, for example, in genetic testing, such as carrier testing, diagnostic testing, predictive and symptomatic testing, etc. In addition, molecular testing is also useful because it can be used to analyze DNA gains or losses that cannot be detected by routine chromosome analysis. Inquire Before Buying: https://www.delvens.com/Inquire-before-buying/genetic-testing-market-trends-forecast-till-2030 sales@delvens.com www.delvens.com

5. Competitive Landscape • Qiagen N.V. (Formulatrix, Inc.) • Eurofins Scientific • Danaher Corporation (Cepheid) • Thermo Fisher Scientific, Inc • F. Hoffmann-La Roche Ltd • Abbott Laboratories • Bio-Rad Laboratories • Illumina, Inc. • 24 genetics • Circle DNA • Tellmegen • 23andme sales@delvens.com www.delvens.com

6. Competitive Landscape • AncestryDNA • MyDNA • Everly Well • Igenomix • VitaGen • Myriad Genetics, Inc. • Mapmygenome • Helix OpCo LLC • MyHeritage Ltd. • Color Genomics, Inc. • Amgen, Inc. • Beyond Nutrition Health and Wellness Services DMCC sales@delvens.com www.delvens.com

7. Regional Analysis • North America to Dominate the Market • North America is estimated to account for the largest market share during the forecast period. In North America, rising demand for diagnostics is mainly due to the increased incidences of chronic illnesses and the availability of technologically advanced diagnostic techniques. In addition, the increasing incidence of infectious diseases in the region, such as COVID-19, tuberculosis, HIV, and influenza, is expected to boost the demand for detection & treatment. • Moreover, the strong presence of well-established healthcare infrastructure and the availability of government funding for research is expected to boost the North American market growth. Purchase This Report: https://www.delvens.com/checkout/genetic-testing-market-trends-forecast-till-2030 sales@delvens.com www.delvens.com

8. Reasons to Acquire • Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors. • Gain authentic and granular data access for the Genetic Testing Market to understand the trends and the factors involved in changing market situations. • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future. • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns. sales@delvens.com www.delvens.com

9. Contact Information About Us: Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally. Contact Us: +44-20-8638-5055 sales@delvens.com WEBSITE: https://delvens.com/ sales@delvens.com www.delvens.com